Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,259,808 | 1,255,623 | 1,326,970 | 1,177,000 | 1,065,390 |
| Depreciation Amortization | 699,328 | 648,225 | 602,890 | 557,000 | 503,220 |
| Income taxes - deferred | 113,790 | 15,913 | N/A | N/A | N/A |
| Accounts receivable | -276,211 | -52,248 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 113,822 | -3,743 | N/A | N/A | N/A |
| Other Working Capital | -245,818 | 136,173 | 211,280 | -288,000 | -227,010 |
| Other Operating Activity | 196,673 | 34,862 | -102,080 | 0 | 26,520 |
| Operating Cash Flow | $1,861,392 | $2,034,805 | $2,039,060 | $1,446,000 | $1,368,120 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -919,954 | -728,091 | -665,640 | -570,000 | -507,520 |
| Net Acquisitions | -1,770,801 | -477,449 | 263,300 | -1,775,000 | 0 |
| Other Investing Activity | 0 | 0 | -1,878,900 | 0 | -617,500 |
| Investing Cash Flow | $-2,690,755 | $-1,205,540 | $-2,281,240 | $-2,345,000 | $-1,125,020 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 501,176 | 400,196 | N/A | N/A | N/A |
| Debt Issued | 2,910,611 | 441,278 | N/A | N/A | N/A |
| Debt Repayment | -1,647,978 | -617,499 | N/A | N/A | N/A |
| Common Stock Issued | 107,047 | 111,300 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | -505,014 | N/A | N/A | N/A |
| Dividend Paid | -317,903 | -296,134 | -271,730 | -281,000 | -231,960 |
| Other Financing Activity | -747,942 | -342,167 | 740,070 | 1,074,000 | 217,250 |
| Financing Cash Flow | $805,011 | $-808,040 | $468,340 | $793,000 | $-14,710 |
| Exchange Rate Effect | -24,570 | -26,488 | 4,590 | 40,000 | -6,730 |
| Beginning Cash Position | 682,777 | 688,040 | 457,290 | 523,000 | 301,220 |
| End Cash Position | 633,855 | 682,777 | 688,040 | 457,000 | 522,870 |
| Net Cash Flow | $-48,922 | $-5,263 | $230,740 | $-66,000 | $221,640 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,861,392 | 2,034,805 | 2,039,060 | 1,446,000 | 1,368,120 |
| Capital Expenditure | -931,627 | -747,938 | N/A | N/A | N/A |
| Free Cash Flow | 929,765 | 1,286,867 | 2,039,060 | 1,446,000 | 1,368,120 |